Tilray shares are about to make a bounce back up. The shares have taken a 70% haircut in 2019, we think it's time to get back in to this stock.
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
marketwatch.com/story/tilray-earnings-show-pot-sales-quintupling-beating-expectations-2019-11-12
finance.yahoo.com/news/tilray-options-traders-call-short-165728411.html
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
marketwatch.com/story/tilray-earnings-show-pot-sales-quintupling-beating-expectations-2019-11-12
finance.yahoo.com/news/tilray-options-traders-call-short-165728411.html
Отказ от ответственности
Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.
Отказ от ответственности
Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.